MedPath

Usefulness of Homoeopathy in the Treatment of urinary tract stones.

Phase 3
Not yet recruiting
Conditions
Urolithiasis,
Registration Number
CTRI/2023/08/056290
Brief Summary

Urolithiasis is the formation of urinary calculi in the urinary system. Urolithiasis is a common, highly recurrent disease with increasing prevalence worldwide. Apart from conservative treatment, extra corporeal shock-wave lithotripsy (ESWL)and ureteroscopy are commonly practiced in conventional medicine in cases of calculi, but these interventions are expensive for the common people and may lead to complications. The possible morbidity, significant cost and the need for highly specialized equipment and special expertise raise the question whether  the current treatments are indeed the most attractive options to meet the increasing demand. Hence it would be worthwhile to look for an alternative, by using homoeopathic medicines for the treatment of urolithiasis.

HYPOTHESES:

A. i) NULL HYPOTHESIS(H0): There is no significant difference in the Urolithiasis Symptoms Score(USS) before and after treatment of urolithiasis with Individualised Homoeopathic (IH) medicines. ➢ ii)ALTERNATIVE HYPOTHESIS (HA): There is a significant difference in the Urolithiasis Symptoms Score(USS) before and after treatment of urolithiasis with Individualised Homoeopathic(IH) medicines.



B. i) NULL HYPOTHESIS(H0): There is no significant difference in the Urolithiasis Symptoms Score(USS) before and after treatment of urolithiasis with Berberis Vulgaris(BV).

ii) ALTERNATIVE HYPOTHESIS (HA): There is a significant difference in the Urolithiasis Symptoms Score(USS) before and after treatment of urolithiasis with Berberis Vulgaris(BV).

C. i) NULL HYPOTHESIS(H0): There is no significant difference in changes (before and after treatment) of Urolithiasis Symptoms Score(USS) in Individualised Homoeopathic (IH)medicines in comparison with Berberis Vulgaris (BV) in the treatment of urolithiasis.

ii) ALTERNATIVE HYPOTHESIS (HA): There is a significant difference in changes (before and after treatment) of Urolithiasis Symptoms Score(USS) in Individualised Homoeopathic (IH) medicines in comparison with Berberis Vulgaris (BV) in the treatment of urolithiasis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
62
Inclusion Criteria
  • 1.Patients diagnosed with urolithiasis (by radiological evidence: Ultrasonography of lower abdomen/K.U.B/C.T/M.R.I etc.) 2.Patients between 20-70 years of age, all religions, all socio-economic status.
  • 3.All sexes, genders, races.
  • 4.Patients who are on lifesaving conventional drug therapies (e,g antidiabetics, antihypertensives, thyroid drugs)to be continued uninterrupted.
  • 6.Patients who are willing to give written consent to participate in the study.
Exclusion Criteria
  • Diagnosed cases of unstable mental or psychiatric illness.
  • 2.Patients who are suffering from any life-threatening illness or other uncontrolled systemic disease affecting quality of life or any other vital organ.
  • 3.Patients who are suffering from any major complication, Congenital Anomalies of Kidney and the Urinary Tract, severe hydronephrosis.
  • 4.Patients who are on active treatment from any other system of medicine.
  • 5.Patients not willing to give consent for participation in the study.
  • 6.Patients not willing to undergo any investigation if advised.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome: Urolithiasis Symptom Score (USS score)Baseline,3rd and 6th month of treatment
On the basis of score obtained from USS index chart, cases according to intensityBaseline,3rd and 6th month of treatment
will be grouped into mild (1-7), moderate (8-14) and severe (15-22). The scores of the initialBaseline,3rd and 6th month of treatment
and follow ups will be compared.Baseline,3rd and 6th month of treatment
Secondary Outcome Measures
NameTimeMethod
Ultrasonography of KUB region at baseline,3rd and 6th month of treatment will be

Trial Locations

Locations (1)

National Institute of Homoeopathy,Kolkata

🇮🇳

Kolkata, WEST BENGAL, India

National Institute of Homoeopathy,Kolkata
🇮🇳Kolkata, WEST BENGAL, India
Dr CHRISTINA LALHRIATPUII
Principal investigator
9163234860
christieswiftie@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.